Results
1 -
10 of
10
(Click
here to explore results)
- PROTAC chemical probes for histone deacetylase enzymes. Urvashi Patel, Joshua P. Smalley, James T. Hodgkinson
, RSC Chem. Biol.
, 2023
, 4
, 623
- Chemically induced degradation of epigenetic targets. Md Kabir, Xufen Yu, H. Ümit Kaniskan, Jian Jin
, Chem. Soc. Rev.
, 2023
, 52
, 4313
- Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6. Alexandria M. Chan, Steven Fletcher
, RSC Med. Chem.
, 2021
, 12
, 178
- Photochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides. D. Wutz, D. Gluhacevic, A. Chakrabarti, K. Schmidtkunz, D. Robaa, F. Erdmann, C. Romier, W. Sippl, M. Jung, B. König
, Org. Biomol. Chem.
, 2017
, 15
, 4882
- Plasticity in designing PROTACs for selective and potent degradation of HDAC6. Haiyan Yang, Wenxing Lv, Ming He, Haiteng Deng, Haitao Li, Wei Wu, Yu Rao
, Chem. Commun.
, 2019
, 55
, 14848
- Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs. Mohd. Muddassir, Kunjal Soni, Chetan B. Sangani, Abdullah Alarifi, Mohd. Afzal, Naaser A. Y. Abduh, Yongtao Duan, Poonam Bhadja
, RSC Adv.
, 2021
, 11
, 612
- Development of the first non-hydroxamate selective HDAC6 degraders. Tim Keuler, Beate König, Nico Bückreiß, Fabian B. Kraft, Philipp König, Linda Schäker-Hübner, Christian Steinebach, Gerd Bendas, Michael Gütschow, Finn K. Hansen
, Chem. Commun.
, 2022
, 58
, 11087
- Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors. D. Diedrich, A. Hamacher, C. G. W. Gertzen, L. A. Alves Avelar, G. J. Reiss, T. Kurz, H. Gohlke, M. U. Kassack, F. K. Hansen
, Chem. Commun.
, 2016
, 52
, 3219
- Assessment of the trifluoromethyl ketone functionality as an alternative zinc-binding group for selective HDAC6 inhibition. Yves Depetter, Silke Geurs, Flore Vanden Bussche, Rob De Vreese, Jorick Franceus, Tom Desmet, Olivier De Wever, Matthias D'hooghe
, Med. Chem. Commun.
, 2018
, 9
, 1011
- Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities. Ji Liu, Tingting Wang, Xinyang Wang, Lin Luo, Jing Guo, Yanfu Peng, Qibing Xu, Jiefei Miao, Yanan Zhang, Yong Ling
, Med. Chem. Commun.
, 2017
, 8
, 1213